Income statement
USD
Annual
| Metric | 2007 | 2006 | 2005 |
|---|---|---|---|
| Revenue | 99K | 115K | 114K |
| Gross Profit | 15K | 25K | 27K |
| Operating Income | -432K | -538K | -211K |
| EBITDA | -432K | -529K | -200K |
| Net Income | -432K | -538K | -211K |
| EPS (Diluted) | — | — | — |
Healthcare
Live Price
Offline$0.0013
-7.14% today
1Y Change
+16.67%
Window
Jun 23, 2025 → Jun 5, 2026
Coverage: 185 bars · Jun 23, 2025 → Jun 5, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Synbio International, Inc. (SYIN) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 16.7% across the available one-year price window (Jun 23, 2025 → Jun 5, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 769.8%. Stock Foundry combines SYIN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SYIN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SYIN Max Drawdown
-78.95%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SYIN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$114.0K
-0.8% YoY
FY Net Income
-$211.2K
+60.7% YoY
Free Cash Flow
-$100.3K
+72.4% YoY
Revenue Growth
+0.0%
EPS Growth
+0.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2007 | 2006 | 2005 |
|---|---|---|---|
| Revenue | 99K | 115K | 114K |
| Gross Profit | 15K | 25K | 27K |
| Operating Income | -432K | -538K | -211K |
| EBITDA | -432K | -529K | -200K |
| Net Income | -432K | -538K | -211K |
| EPS (Diluted) | — | — | — |
Balance sheet
USD
| Metric | 2007 | 2006 | 2005 |
|---|---|---|---|
| Cash & Equivalents | 22K | 49K | 12K |
| Total Assets | 146K | 538K | 774K |
| Total Liabilities | 229K | 93K | 493K |
| Shareholder Equity | -83K | 445K | 281K |
| Total Debt | 55K | 69K | 375K |
| Net Debt | 33K | 20K | 363K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
99K
+72.9% YoY
Capital Expenditures
2K
Free Cash Flow
100K
+72.4% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
19.6%
Debt / Equity
-0.22x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.